What is the Quality Summit (QS)?
The Quality Summit (QS) is a year-long endeavor, designed to foster conversation among key stakeholders and government leaders about the effectiveness of the existing portfolio of healthcare quality programs currently administered by the Department of Defense (DOD), Department of Veterans Affairs (VA), and the Department of Health and Human Service’s (HHS) Centers for Medicare & Medicaid Services (CMS), Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration (HRSA), and Indian Health Service (IHS). The QS will be a first step in evaluating current quality programs under the directive of President Trump’s Executive Order 13877, Improving Price and Quality Transparency in American Healthcare To Put Patients First.
Using the information gathered, in the first 6 months of the Summit, HHS will establish a Health Quality Roadmap to align and improve reporting on data and quality measures across Medicare, Medicaid, the Children’s Health Insurance Program, the Health Insurance Marketplace, the Military Health System, and the Veteran’s Affairs Health System.
The Quality Summit is being organized by the Immediate Office of the Secretary of HHS, and chaired by Deputy Secretary Eric Hargan. The co-chair is Peter Pronovost, M.D., Ph.D., Advisor for Value-Based Care and Health Insurance at HHS, and an internationally renowned expert on healthcare quality and patient safety.
Who is included as external participants at the Quality Summit?
The Office of the Deputy Secretary of Health and Human Services is pleased to announce the participants in the Quality Summit:
|Shantanu Agrawal||Chief Executive Officer||National Quality Forum|
|Leah Binder||Chief Executive Officer||Leapfrog Group|
|David Blumenthal||Chief Executive Officer||Commonwealth Fund|
|Twila Brase||Co-Founder and President||Citizens Council for Health Freedom|
|Sally Brooks||Chief Medical Officer||Kindred Health|
|Mary Ann Fuchs||Chief Nursing Officer||American Organization of Nurse Executives|
|Nancy Gin||Chief Quality Officer||Kaiser Permanente|
|William Kassler||Chief Medical Officer||IBM Watson|
|David Lansky||Senior Advisor||Pacific Business Group on Health|
|Danielle Lloyd||Senior Vice President||America's Health Insurance Plans|
|Mary Mayhew||Secretary||Florida Agency for Health Care Administration|
|Roberto Martinez||Chief Medical Officer||Doctors Hospital at Renaissance|
|Peggy O'Kane||President||National Committee for Quality Assurance|
|Jonathan Perlin||Chief Medical Officer||HCA|
|Thomas Priselac||Chief Executive Officer||Cedars Sinai|
|Jack Resneck||Professor||University of California, San Francisco|
|Henry Ting||Chief Quality Officer||Mayo Clinic|
|Larry Van Horn||Professor||Vanderbilt School of Business|
Participants were invited from a field of over 300 qualified applicants. They will engage in a dialogue with HHS leaders about the government’s role in assuring quality in healthcare delivery. The Deputy Secretary’s Office would like to thank all applicants for taking an interest in this important effort.
Is HHS committing to restructuring governmental quality programs based solely on input from this group?
No. This group will not be recommending or giving any direction on healthcare quality programs administered by the government. HHS is looking to engage with this group to better understand the healthcare quality management landscape, and the opportunities, barriers, and misunderstandings that exist. This is an attempt by HHS to get a broader set of perspectives on how healthcare quality is assured, how healthcare quality and patient safety can be improved, and the respective roles of governmental and non-governmental stakeholders in that process.
What does success look like for this effort?
The Federal Government hopes to gain stakeholder input from the Quality Summit to inform the development of a Quality Roadmap for establishing, adopting, and publishing common quality measurements; aligning inpatient and outpatient measures; and eliminating low-value or counterproductive measures. This includes, among other things, a better understanding of the administrative burden that has prevented, or currently prevents, broad adoption of meaningful quality measures to inform decision making for patients, providers, and healthcare systems. Participants will comment on how and why they use quality information, frameworks and strategies for quality improvement, and the role of quality measurements in improving outcomes (e.g., patient, structural, clinical, systemic, and process).